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Abstract
Purpose Alcohol intake may be associated with cancer
risk, but epidemiologic evidence for prostate cancer is
inconsistent. We aimed to prospectively investigate the
association between midlife alcohol intake and drinking
patterns with future prostate cancer risk and mortality in a
population-based cohort of Finnish twins.
Methods Data were drawn from the Older Finnish Twin
Cohort and included 11,372 twins followed from 1981 to
2012. Alcohol consumption was assessed by questionnaires
administered at two time points over follow-up. Over the
study period, 601 incident cases of prostate cancer and 110
deaths from prostate cancer occurred. Cox regression was
used to evaluate associations between weekly alcohol
intake and binge drinking patterns with prostate cancer risk
and prostate cancer-specific mortality. Within-pair co-twin
analyses were performed to control for potential con-
founding by shared genetic and early environmental
factors.
Results Compared to light drinkers (B3 drinks/week; non-
abstainers), heavy drinkers ([14 drinks/week) were at a
1.46-fold higher risk (HR 1.46; 95 % CI 1.12, 1.91) of
prostate cancer, adjusting for important confounders.
Among current drinkers, binge drinkers were at a signifi-
cantly increased risk of prostate cancer (HR 1.28; 95 % CI
1.06, 1.55) compared to non-binge drinkers. Abstainers
were at a 1.90-fold higher risk (HR 1.90; 95 % CI 1.04,
3.47) of prostate cancer-specific mortality compared to
light drinkers, but no other significant associations for
mortality were found. Co-twin analyses suggested that
alcohol consumption may be associated with prostate
cancer risk independent of early environmental and genetic
factors.
Conclusion Heavy regular alcohol consumption and binge
drinking patterns may be associated with increased prostate
cancer risk, while abstinence may be associated with
increased risk of prostate cancer-specific mortality com-
pared to light alcohol consumption.
Keywords Alcohol  Binge drinking  Prospective cohort
study  Prostate cancer  Twins
Introduction
Alcohol is an established risk factor for cancers of the oral
cavity, pharynx, larynx, esophagus, liver, colorectum, and
female breast, but evidence for an association between
alcohol and prostate cancer is inconsistent [1–3]. There is
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biologic rationale that alcohol or its metabolites (e.g.,
acetaldehyde) could increase prostate cancer risk by acting
as a carcinogen or by modulating risk from other car-
cinogens [4–7]. Since alcohol consumption is a common
and modifiable lifestyle factor, even a modest association
with prostate cancer risk would be of public health
significance.
Over 70 epidemiologic studies have explored the rela-
tionship between alcohol and prostate cancer, but findings
have been mixed and critical gaps remain [reviewed in 1;
8–11]. While most studies have reported evidence of little
to no association between alcohol consumption within
normal range and prostate cancer risk overall, [1, 11–13]
some have suggested an elevated risk among heavy drin-
kers [14–22]. The risk associated with heavy regular
alcohol intake as well as binge drinking patterns deserves
further exploration. The influence of midlife alcohol con-
sumption on later prostate cancer risk is also of great
interest given the long latency of prostate cancer and bio-
logic plausibility that alcohol may act as a promoter of this
disease [5]. Finally, prospective study designs and unique
analytic methods are needed to minimize the possibility
that the modest associations that have been detected could
be explained by unknown confounders or biases inherent to
many observational studies.
We aimed to prospectively investigate the influence of
midlife alcohol intake and drinking patterns on prostate
cancer risk later in life in the Older Finnish Twin Cohort, a
population-based cohort of male twins with a median of
30 years of follow-up data, a wide range of alcohol con-
sumption assessed at two time points, and a high preva-
lence of reported binge drinking. In addition to examining
the risk of prostate cancer diagnosis, we explored the risk
of prostate cancer-specific mortality, which reflects the
most clinically aggressive disease. A detailed examination
of these associations has never before been explored in a
prospective study of male twins—a setting that allows for
the application of powerful analytic methods to control for
potential familial confounding (genetics and shared early
environment). We hypothesize that high levels of average
weekly alcohol consumption and binge drinking behavior
are associated with increased prostate cancer risk.
Materials and methods
Study population
This study was nested within the Older Finnish Twin
Cohort, consisting of all Finnish same-sex twin pairs born
before 1958 with both co-twins alive in 1975. Twin pairs
were selected from the Central Population Registry of
Finland in 1974. Twin zygosity was determined by a
validated questionnaire shown to accurately classify
[93 % of twin pairs as monozygotic (MZ) or dizygotic
(DZ) [23]. This survey included questions on whether
twins resembled one another and whether strangers would
confuse them in childhood and was validated against
polymorphic blood markers. Questionnaires were mailed to
participants in 1975 and 1981, with response rates of 89
and 84 %, respectively. They contained questions on life-
style factors such as alcohol consumption, smoking, and
physical activity, in addition to comprehensive questions
on socio-demographic, psychosocial, and health factors. A
total of 11,372 male twin individuals responded to both the
1975 and 1981 questionnaires and were free of prostate
cancer in 1981. Among these men, there were 1,290
monozygotic (MZ) and 2,858 dizygotic (DZ) twin pairs, in
addition to 442 twin pairs of uncertain zygosity. In addi-
tion, there were 423 singleton twins (twins without their
co-twin in the study) of unknown zygosity, 457 singleton
MZ twins, and 1,312 singleton DZ twins. Of these 11,372
men, 11,363 provided information on alcohol intake (reg-
ular consumption in 1975 and 1981 and/or binge drinking
in 1981). A total of 11,352 men contributed to the regular
alcohol consumption analyses, and 11,164 men contributed
to the binge drinking analyses (11,153 of whom also had
data on regular alcohol consumption and 11 of whom had
data on binge drinking only). The mean age (±standard
deviation) of participants at the time of study entry was
40.1 years (±12.5).
The study was approved by the ethical committee of the
Hjelt Institute, Faculty of Medicine, University of Helsinki.
Permission for linkage of the cancer registry data was
provided by the National Institute for Health and Welfare,
Helsinki, Finland. Informed consent was obtained from all
respondents.
Exposure assessment
Given the long latency of prostate cancer, we were inter-
ested in the influence of midlife alcohol intake on prostate
cancer risk and mortality later in life. Information on
alcohol intake was obtained on both the 1975 and 1981
questionnaires by asking respondents to report the quantity
of beer and wine consumed in an average week and the
quantity of spirits consumed in an average month. The
amount of alcohol consumed was measured on 3 separate
scales (one for each type of alcoholic beverage), with the
upper limits defined as consuming C48 bottles of beer/
week, C10 bottles of wine/week, and C20 bottles of spir-
its/month (defined as any alcohol stronger than fortified
wine). In 1975 and 1981 in Finland, beer bottles were
almost exclusively 0.33 L, wine bottles were generally
0.75 L, and vodka (the most common spirit being used)
was sold in 0.5 L bottles. Reported consumption of each
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beverage type was converted into grams of absolute alco-
hol and summed to create total alcohol intake in grams/
week. We averaged estimates from the 1975 and 1981
questionnaires to estimate average alcohol intake in units
of grams/week. We then converted this average to a value
of drinks/week, defining one drink as 12 grams of alco-
hol. Current drinkers were classified as light (0.01–3
drinks/week), moderate (3.01–14 drinks/week), or heavy
([14.01 drinks/week) drinkers, per National Institute on
Alcohol Abuse and Alcoholism (NIHAAA) guidelines
[24].
We distinguished lifetime abstainers as those who
reported no alcohol intake on both the 1975 and 1981
questionnaires from former drinkers defined as abstinent on
both the 1975 and 1981 questionnaires, but reported a
history of drinking prior to the 1975 questionnaire. These
two groups, in addition to a small group (n = 115)
reporting abstinence in 1975 or 1981 and missing alcohol
use data in 1975 or 1981, were collapsed into an ‘‘ab-
stainers’’ category that referred to current nondrinkers.
Binge drinkers were those who responded that they had
consumed either:[5 bottles of beer, 1 bottle of wine, or 4
drinks (C18 milliliters of spirits) on the same occasion at
least once a month during the preceding year on the 1981
questionnaire.
Outcome ascertainment
Follow-up of the twin cohort was achieved through linkage
with national health registers in Finland. Data on prostate
cancer incidence (ICD code 185) were obtained through
record linkage to the Finnish Cancer Registry, where
100 % of registered cases are histologically verified.
Cause-of-death data were obtained through linkage with
Statistics Finland. All of those who died from prostate
cancer had a diagnosis of prostate cancer prior to death in
the Finnish Cancer Registry. Data on emigration and vital
status were obtained through linkage to the Population
Register Center of Finland. Data from all registries were
linked to Finnish Twin Cohort data using unique personal
identity codes assigned to every permanent resident of
Finland. The completeness of these registers allows for
essentially complete disease follow-up.
Statistical analysis
Descriptive analyses (frequencies and means) were calcu-
lated to characterize the study population and examine
differences in potential confounders across categories of
average weekly alcohol consumption. Our primary expo-
sures of interest were average weekly alcohol consumption
and binge drinking among current drinkers. Cox propor-
tional hazard models were used to estimate age-adjusted
hazard ratios (HRs) with 95 % confidence intervals (CIs)
for the outcomes of prostate cancer incidence and prostate
cancer-specific mortality. Each participant’s date of entry
was defined as his exact age when the 1981 questionnaire
was returned. Participants were followed prospectively
through 31 December 2012 for the occurrence of prostate
cancer, death from any cause, or emigration. Log–log plots
of survival curves of average weekly alcohol consumption
and binge drinking status were used to verify that the
curves were parallel and the proportional hazards
assumption was not violated. Age was the underlying time
metameter. Our final multivariable models were adjusted
for potential confounding variables: BMI (continuous),
smoking (never, occasional, former, current), social class
(upper white collar, lower white collar, skilled worker,
unskilled worker, farmer, other), education (\6 years,
6 years, middle school, high school, or more), and physical
activity (sedentary, occasional exerciser, conditioning
exerciser). Risk estimates for alcohol use remained
stable whether social class and education were included
together in the model or not (data not shown). Due to the
dependent nature of our study population (twin pairs),
standard errors and CIs were adjusted for possible within-
pair correlations using robust variance estimators.
We further performed co-twin analyses to investigate
the association between alcohol consumption and prostate
cancer risk within twin pairs discordant for alcohol intake
category and time to event (i.e., time to prostate cancer
diagnosis among twin pairs concordant for prostate cancer
outcome, and time to event vs. death or end of follow-up
among twin pairs discordant for prostate cancer outcome;
see Supplementary Figure 1). These Cox models were
stratified on twin pairs, allowing each twin pair to have its
own baseline hazard. This serves as a powerful approach to
account for familial confounding (genetics and shared early
environment) when assessing twins discordant for alcohol
consumption and prostate cancer outcomes. If the associ-
ation between alcohol consumption and prostate cancer
were rooted in familial factors, one would expect an
association to exist between twin pairs (in individual-based
analyses of the entire cohort) but not within twin pairs
raised in the same household [25]. On the other hand, if the
association were rooted in genetic factors, then the asso-
ciation should be present within DZ twin pairs (sharing on
average 50 % of their segregating genes) but not within
MZ twin pairs (sharing 100 % of their genome sequence).
Lastly, if the association were rooted in non-familial
environmental factors (independent of genetics and shared
early environment), then the association should be present
within both DZ and MZ twin pairs. Non-familial environ-
mental factors include all environmental factors unique to
twin individuals as well as direct causal associations
between alcohol consumption and prostate cancer.
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We performed a predefined subgroup analysis to explore
a potential interaction between average weekly alcohol
consumption and smoking status (never, former, occa-
sional, daily). The presence of effect modification was
assessed by entering product terms of average weekly
alcohol intake and smoking status categories into the model
and estimating likelihood ratio tests comparing models
with and without the interaction terms.
Finally, we explored the association between our mea-
sures of alcohol consumption and alcohol-related causes of
death (alcoholism, alcoholic liver disease, and alcoholic
pancreatitis). We calculated the relative proportion of
deaths due to alcohol-related causes for each category of
average alcohol consumption. We also performed Cox
regression to examine associations between average
weekly alcohol consumption and risk of alcohol-related
death. Because alcohol-related causes of death require
heavy alcohol use for a long period of time, this approach
enabled us to explore the stability of alcohol consumption
category over time.
All statistical tests were two-sided, and p values\0.05
were considered statistically significant. All statistical
analyses were performed using Stata version 13.1 (Stata
Corporation, College Station, TX, USA).
Results
Over a median of 30 years of follow-up, 601 incident cases
of prostate cancer and 110 deaths from prostate cancer
occurred. The mean age (±standard deviation) of partici-
pants at the time of prostate cancer diagnosis was
69.9 years (±8.9).
Baseline characteristics of participants are displayed in
Table 1 by category of average alcohol consumption
(drinks/week). The distribution of average weekly alcohol
consumption in this study population was as follows: 7 %
abstainers, 31 % light drinkers, 46 % moderate drinkers,
and 17 % heavy drinkers. Light drinkers consumed a mean
of 1.7 drinks/week, moderate drinkers consumed a mean of
7.1 drinks/week, and heavy drinkers consumed a mean of
24.1 drinks/week. Heavy drinkers were younger, had a
higher BMI, and were more likely to be current smokers
and binge drinkers compared to those in other drinking
categories.
Prostate cancer diagnosis
In the overall study population, average weekly alcohol
consumption (continuous) was significantly associated with
prostate cancer risk in age-adjusted models, whereby each
additional drink consumed per day was associated with a
10 % increase in prostate cancer risk (HR 1.10; 95 % CI
1.05, 1.15). Exclusion of abstainers did not influence the
relative risk estimate (data not shown).
Modeling average weekly alcohol consumption as a
categorical variable, we found a positive association with
prostate cancer risk among moderate (HR 1.20; 95 % CI
0.99, 1.46) and heavy drinkers (HR 1.46; 95 % CI 1.12,
1.91) compared to light drinkers in multivariable models
(Table 2). Results using abstinent men as the reference
group are displayed in Supplementary Table 1. Among
current drinkers, binge drinkers were at a significantly
increased risk of prostate cancer compared to non-binge
drinkers in age-adjusted (HR 1.35; 95 % CI 1.12, 1.61) and
multivariable (HR 1.28; 95 % CI 1.06, 1.55) models
(Table 2).
Among the twin pairs, 354 twin pairs were discordant
for prostate cancer outcome, such that one twin was a
prostate cancer case and his co-twin brother was not. Of
these 354 pairs, 195 were also discordant for average
weekly alcohol consumption category (Table 3) and 102
were discordant for binge drinking status. Supplementary
Tables 2 and 3 display counts of exposure and outcome
concordance for DZ and MZ twin pairs, respectively.
Prostate cancer risk estimates obtained from pairwise twin
analyses were consistently higher than those obtained from
individual-based analyses. Within twin pairs, abstainers
were at the highest risk of prostate cancer compared to their
light drinker brothers (HR 2.98; 95 % CI 1.35, 6.60)
(Table 4). This elevated risk remained statistically signifi-
cant among DZ twin pairs (HR 3.80; 95 % CI 1.36, 20.6)
but not among MZ twin pairs (HR 2.85; 95 % CI 0.67,
12.1). Pairwise analysis results using abstinent men as the
reference group are displayed in Supplementary Table 4.
Within discordant twin pairs, binge drinking was sugges-
tively, but not significantly, associated with an increased
risk of prostate cancer (HR 1.47; 95 % CI 0.96, 2.25)
(Table 5). In sensitivity analyses, pairwise analyses
restricted to twin pairs discordant for prostate cancer out-
come produced similar estimates but with wider confidence
intervals (data not shown).
Prostate cancer-specific mortality
In the overall study population, average weekly alcohol
consumption (continuous) was positively associated with
prostate cancer mortality (HR 1.06; 95 % CI 0.91, 1.23),
although not statistically significant (data not shown).
Modeling average weekly alcohol consumption as a
categorical variable, abstainers were at a significantly
higher risk of death from prostate cancer (HR 1.90; 95 %
CI 1.04, 3.47) compared to light drinkers (Table 2). We
decomposed this group of current nondrinkers (in both
1975 and 1981) into lifetime abstainers (n = 588) and
former drinkers (i.e., prior to 1975; n = 78) to assess the
1052 Cancer Causes Control (2016) 27:1049–1058
123
risk associated with each distinct subgroup. Lifetime
abstainers were at a significantly increased risk of prostate
cancer-specific mortality (HR 2.18; 95 % CI 1.19, 3.99),
and former drinkers were at a nonsignificantly increased
risk (HR 1.91; 95 % CI 0.45, 8.22) compared to light
drinkers (data not shown). We also observed an increased
Table 1 Baseline characteristics across categories of average alcohol consumption in drinks/week (average of 1975 and 1981), Older Finnish
Twin Cohort, 1981–2012





(n = 781; 6.9 %)
Light drinker
0.01–3 drinks/week
(n = 3,496; 30.7 %)
Moderate drinker
3.01–14 drinks/week
(n = 5,175; 45.5 %)
Heavy drinker
14.01? drinks/week
(n = 1,900; 16.7 %)
Mean (SD)
Age at baseline, 1981 40.1 (12.5) 44.1 (15.0) 41.7 (14.0) 38.9 (11.7) 39.1 (10.5)
BMI 24.5 (3.0) 24.5 (3.4) 24.3 (3.0) 24.5 (2.9) 25.1 (3.3)
N (%)
Smoking status
Never 3,378 (29.8) 484 (62.0) 1,580 (45.2) 1,110 (21.4) 204 (10.7)
Occasional 441 (3.9) 22 (2.8) 132 (3.8) 233 (4.5) 54 (2.8)
Former 3,086 (27.2) 160 (20.5) 952 (27.2) 1,559 (30.1) 415 (21.8)
Current 4,204 (37.0) 100 (12.8) 759 (21.7) 2,156 (41.7) 1,189 (62.6)
Missing 243 (2.1) 15 (1.9) 73 (2.1) 117 (2.3) 38 (2.0)
Social class
Upper white collar 884 (7.8) 40 (5.1) 225 (6.4) 453 (8.8) 166 (8.7)
Lower white collar 1,951 (17.2) 108 (13.8) 604 (17.3) 924 (17.9) 315 (16.6)
Skilled worker 4,797 (42.2) 255 (32.7) 1,379 (39.4) 2,328 (45.0) 835 (43.9)
Unskilled worker 1,024 (9.0) 73 (9.3) 312 (8.9) 433 (8.4) 206 (10.8)
Farmer 946 (8.3) 136 (17.4) 477 (13.6) 270 (5.2) 63 (3.3)
Other/unknown 1,750 (15.4) 169 (21.6) 499 (14.3) 767 (14.8) 315 (16.6)
Education
\6 years 255 (2.2) 34 (4.4) 84 (2.4) 100 (1.9) 37 (1.9)
6 years 4,354 (38.4) 348 (44.6) 1,418 (40.6) 1,875 (36.2) 713 (37.5)
Middle school 4,643 (40.9) 243 (31.1) 1,440 (41.2) 2,224 (43.0) 736 (38.7)
High school or more 1,111 (9.8) 49 (6.3) 326 (9.3) 556 (10.7) 180 (9.5)
Missing 989 (8.7) 107 (13.7) 228 (6.5) 420 (8.1) 234 (12.3)
Physical activity
Sedentary 1,482 (13.1) 141 (18.1) 436 (12.5) 564 (10.9) 341 (17.9)
Occasional exerciser 7,955 (70.1) 554 (70.9) 2,428 (69.5) 3,653 (70.6) 1,320 (69.5)
Conditioning exerciserc 1,915 (16.9) 86 (11.0) 632 (18.1) 958 (18.5) 239 (12.6)
Binge drinking statusd
Yes 4,723 (41.6) 0 (0) 276 (7.9) 2,777 (53.7) 1,670 (87.9)
No 6,430 (56.6) 730 (93.5) 3,159 (90.4) 2,330 (45.0) 211 (11.1)
Missing 199 (1.8) 51 (6.5) 61 (1.7) 68 (1.3) 19 (1.0)
BMI body mass index, calculated from self-reported height and weight; MET metabolic equivalents
a N = 11,352 participants had data on average alcohol consumption category
b Abstainers refer to lifetime abstainers, former drinkers (those who were abstinent in both 1975 and 1981 but reported a history of drinking prior
to the 1975 questionnaire), as well as participants who reported abstinence in 1975 or 1981 and were missing alcohol use data in 1975 or 1981
c Conditioning exerciser refers to those reporting exercising at least 6 times per month for a mean duration of at least 30 min and with a mean
intensity corresponding to at least vigorous walking to jogging
d Binge drinking status refers to reported consumption of[5 bottles of beer, 1 bottle of wine, or 4 drinks (C18 mL of spirits) on the same
occasion at least once a month during the preceding year
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risk of mortality among moderate (HR 1.22; 95 % CI 0.76,
1.97) and heavy drinkers (HR 1.32; 95 % CI 0.66, 2.62)
compared to light drinkers.
Within discordant twin pairs, binge drinkers were also at
a higher risk of mortality compared to their non-binge
drinker brothers, although confidence intervals were wide
and included the null (Table 5).
No significant interactions between alcohol consump-
tion and smoking status were found (Pinteraction[ 0.4; data
not shown).
Alcohol-related cause of death
The proportion of deaths due to alcohol-related causes in
each category of cumulative average alcohol consumption
was as follows: 0.4 % of abstainers, 0.8 % of light drin-
kers, 3.8 % of moderate drinkers, and 10.4 % of heavy
drinkers. The hazard ratios of alcohol-related death were
1.75 for light drinkers (95 % CI 0.22, 13.96), 8.19 for
moderate drinkers (95 % CI 1.14, 58.75), and 39.18 for
heavy drinkers (95 % CI 5.51, 278.53) (data not shown).
These findings provide support that participants’ alcohol
consumption category remained stable over time.
Discussion
Our study provided the unique opportunity to investigate
the association between midlife average weekly alcohol
intake, binge drinking patterns, and future prostate cancer
Table 2 Average weekly alcohol consumption category (average of 1975 and 1981), binge drinking status (1981), and prostate cancer risk and
mortality (HR, 95 % CI), Older Finnish Twin Cohort, 1981–2012
Person-years Prostate cancer incidence Prostate cancer-specific mortality
No. events Age-adjusted Fully adjusteda No. events Age-adjusted Fully adjusteda
HR 95 % CI HR 95 % CI HR 95 % CI HR 95 % CI
Alcohol consumption categoryb
Light drinkers 89,453 185 1.00 (ref) 1.00 (ref) 33 1.00 (ref) 1.00 (ref)
Abstainersc 18,993 56 1.21 0.90, 1.62 1.27 0.94, 1.71 17 1.95 1.10, 3.48 1.90 1.04, 3.47
Moderate drinkers 135,646 266 1.26 1.05, 1.52 1.20 0.99, 1.46 45 1.24 0.79, 1.93 1.22 0.76, 1.97
Heavy drinkers 45,250 94 1.55 1.21, 1.99 1.46 1.12, 1.91 15 1.47 0.79, 2.73 1.32 0.66, 2.62
Binge drinking statusd
No 145,568 326 1.00 (ref) 1.00 (ref) 60 1.00 (ref) 1.00 (ref)
Yes 122,088 206 1.35 1.12, 1.61 1.28 1.06, 1.55 27 1.01 0.63, 1.60 0.87 0.52, 1.45
The bolded values were statistically significant at the 0.05 level of confidence (p\ 0.05)
a Fully adjusted for the following variables: BMI, smoking, social class, education, physical activity
b Light drinker (average of 0.01–3 drinks/week), moderate drinker (average of 3.01–14 drinks/week), and heavy drinker (average of[14 drinks/
week)
c Abstainers include both lifetime abstinent participants and former drinkers who were abstinent in both 1975 and 1981
d Binge drinking models excluded abstainers
Table 3 Average weekly alcohol consumption category among 354 twin pairs discordant for prostate cancer outcome, Older Finnish Twin
Cohort, 1981–2012
Average weekly alcohol consumption category
for his unaffected co-twin brother
Average weekly alcohol consumption category for case twin
Abstainer Light Moderate Heavy Total
Abstainer 8 6 2 0 16
Light 15 48 44 10 117
Moderate 4 36 81 31 152
Heavy 5 8 34 22 69
Total 32 98 161 63 354
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risk and mortality while controlling for potential familial
confounding (genetics and shared early environment) in a
large population of male twins. To the best of our knowl-
edge, this study is the first of its kind to leverage co-twin
analyses in the investigation of this association. Altogether,
our data support the hypothesis that heavy regular alcohol
intake and binge drinking patterns are associated with an
increased risk of prostate cancer. They also suggest that
abstinence may be associated with an increased risk of
prostate cancer-specific mortality compared to light regular
alcohol consumption. Our co-twin analyses suggest that
heavy regular alcohol consumption as well as binge
drinking may be associated with a higher risk of prostate
cancer incidence and mortality independent of familial and
genetic factors. However, this finding should be interpreted
with caution given the small number of discordant pairs in
the co-twin analyses.
There is biologic rationale that heavy regular or binge
drinking of alcohol may increase prostate cancer risk via
production of carcinogenic metabolites such as acetalde-
hyde, promotion of oxidative stress, enhancement of car-
cinogen solubility and absorption, and inhibition of
detoxification and DNA methylation pathway enzymes
[2, 18]. Conversely, high alcohol intake may lower
testosterone levels—an altered hormonal profile that might
be expected to decrease prostate cancer risk [18]. These
physiologic changes may impact different stages of pros-
tate carcinogenesis. It has been suggested that increased
Table 4 Weekly alcohol
consumption categorya and
prostate cancer risk and
mortality: pairwise analyses
(HR, 95 % CI), Older Finnish
Twin Cohort, 1981–2012






HR 95 % CI HR 95 % CI HR 95 % CI
Light drinkers 1.00 (ref) 1.00 (ref) 1.00 (ref)
Abstainers 2.85 0.67, 12.1 3.80 1.36, 20.6 2.98 1.35, 6.60
Moderate drinkers 1.28 0.60, 2.74 1.54 0.92, 2.57 1.36 0.91, 2.04
Heavy drinkers 2.00 0.62, 6.45 1.71 0.87, 3.39 1.63 0.92, 2.88






HR 95 % CI HR 95 % CI HR 95 % CI
Light drinkers 1.00 (ref) 1.00 (ref) 1.00 (ref)
Abstainers 2.31 0.19, 27.4 1.83 0.42, 8.03 1.37 0.44, 4.28
Moderate drinkers 9.13 0.70, 119 1.43 0.37, 5.62 2.44 0.79, 7.52
Heavy drinkers – – 2.39 0.33, 17.3 7.31 1.30, 41.0
The bolded values were statistically significant at the 0.05 level of confidence (p\ 0.05)
a Light drinker (average of 0.01–3 drinks/week), moderate drinker (average of 3.01–14 drinks/week), and
heavy drinker (average of[14 drinks/week)
b Number of twin pairs discordant for weekly alcohol consumption category and time to event (i.e., time to
prostate cancer diagnosis among twin pairs concordant for prostate cancer outcome, and time to event vs.
death or end of follow-up among twin pairs discordant for prostate cancer outcome)
Table 5 Binge drinking status
and prostate cancer risk and
mortality: pairwise analyses
(HR, 95 % CI), Older Finnish
Twin Cohort, 1981–2012






HR 95 % CI HR 95 % CI HR 95 % CI
Binge drinking status, yes versus no 1.78 0.79, 4.02 1.46 0.87, 2.45 1.47 0.96, 2.25






HR 95 % CI HR 95 % CI HR 95 % CI
Binge drinking status, yes versus no 3.00 0.31, 28.8 1.25 0.34, 4.65 1.80 0.60, 5.37
a Number of twin pairs discordant for binge drinking status and time to event (i.e., time to prostate cancer
diagnosis among twin pairs concordant for prostate cancer outcome, and time to event vs. death or end of
follow-up among twin pairs discordant for prostate cancer outcome)
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oxidative stress may adversely impact early stages, while
altered hormonal profiles may favorably impact later pro-
motion [18]. Consistent with this hypothesis, in the present
study we found that heavy regular and binge drinking had a
larger impact on prostate cancer incidence than on mor-
tality. The biologic impact of alcohol is complex, and
further investigation is needed to explore how the balance
between its potentially adverse and protective effects varies
by exposure level and how this impacts different stages of
prostate carcinogenesis and grades of disease.
Despite the biologic plausibility of an association
between alcohol and prostate cancer, the epidemiologic
evidence has been inconsistent. A meta-analysis of 50
case–control and 22 cohort studies reported a modest
association between alcohol intake and total prostate can-
cer risk (RR 1.05 [95% CI 1.02, 1.09] for light drinkers
(0–7 drinks/week), RR 1.06 [95 % CI 1.01, 1.11] for
moderate drinkers (7–28 drinks/week), and RR 1.08 [95 %
CI 0.97, 1.20] for heavy drinkers (C28 drinks/week); ref-
erence = non/occasional drinkers) [11]. A more recent
meta-analysis of 23 case–control and 20 cohort studies
reported similar estimates for the association between
alcohol consumption and prostate cancer risk (RR 1.04
[95 % CI 1.01, 1.08] for light drinkers, RR 1.06 [1.01,
1.11] for moderate drinkers, and RR 1.09 [95 % CI 0.98,
1.21] for heavy drinkers; reference = non/occasional
drinkers) [1]. Of these studies, 39 reported on prostate
cancer incidence and 4 reported on mortality as the out-
come of interest. Authors of this meta-analysis considered
as light, moderate, and heavy drinking every interval of
alcohol intake whose midpoint was, respectively, B12.5,
B50, and [50 g/day of alcohol. Trends of increasing
prostate cancer risk across increasing levels of alcohol
consumption have been reported [1, 11], but the statistical
significance of point estimates is typically lost at the
highest levels of intake. In the present study, we found a
significant trend of increasing prostate cancer risk with
increasing average weekly alcohol consumption as well as
a significant association between heavy regular drinking
and prostate cancer risk. Furthermore, this association was
of a stronger magnitude than the aforementioned estimates
from meta-analyses [1, 11].
We also found that binge drinking consumption patterns
were associated with a significantly increased risk of pros-
tate cancer. Others have similarly found a positive associ-
ation between infrequent consumption of large amounts of
alcohol and prostate cancer risk [18, 26]. These findings
highlight the importance of accounting for both frequency
and quantity of alcohol intake, as different drinking patterns
may be associated with different physiologic effects and
implications for prostate cancer risk and mortality.
The inconsistency across epidemiologic reports might
be rooted in a variety of factors. Case–control studies are
sensitive to recall and selection bias, alcohol intake in
many study populations is often limited to a narrow range,
and investigators utilize varying methods of reporting
alcohol consumption (i.e., different units of alcohol per
duration of time, different reference groups). Individual
levels of alcohol consumption vary considerably over time,
but many studies have been based on alcohol intake
assessed at a single time point. Finally, ecological studies
report major differences in prostate cancer rates around the
world, suggesting that environmental factors may play a
role in the development of this disease [27]. Estimates may
therefore be affected by residual confounding by environ-
mental factors that have yet to be identified with certainty.
The unique nature of our study population and analytic
approach allowed us to address these limitations. The
prospective, population-based design of our study mini-
mizes the likelihood of recall and selection bias. The
standardized incidence ratio of prostate cancer in our
cohort compared to Finnish Cancer Registry data was 1.00
(95 % CI 0.92–1.08). The distribution of alcohol intake in
this population was broad, binge drinking rates were high,
and we were able to leverage data assessed at two different
time points to account for variation in midlife drinking
habits over follow-up. We also repeated analyses using
abstinent men as the reference group for comparison to
other studies (Supplementary Tables 1 and 4). Co-twin
analyses allowed us to account for the potentially con-
founding effects of genetics and shared early environment,
since each matched set consisted of a twin pair. Our find-
ings suggest that non-familial environmental factors
(unique environmental factors as well as direct causal
associations) are at play in the associations between heavy
regular drinking, binge drinking, and prostate cancer risk
and mortality, given the consistently elevated risk esti-
mates across all discordant pairs compared to individual-
based analyses. These results could also be due to chance
despite our large overall study population; the number of
discordant twin pairs was insufficient to supply the power
needed to confirm these findings with statistical confidence.
Thus, we also cannot exclude the possibility of some
familial confounding due to shared environmental and
genetic factors. These could be addressed with Mendelian
randomization studies that use genetic variants associated
with alcohol use and prostate cancer risk as instrumental
variables, as has been conducted for the alcohol–coronary
heart disease association [28].
Important strengths of our study include its prospective
design, long duration of follow-up, large population-based
sample, complete and reliable outcome data obtained
through registry linkage, high questionnaire response rate
with two assessments (84–89 %), and detailed assessment
of socio-demographic, psychosocial, and health factors. In
addition to examining total prostate cancer risk, we
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examined risk of prostate cancer-specific mortality, which
reflects the most aggressive prostate tumors. Several limi-
tations should be noted. The low number of discordant twin
pairs available for the co-twin analyses did not provide
sufficient statistical power to draw strong conclusions on
familial confounding. Also, the Caucasian background of
this Finnish population may limit the generalizability of
these findings to more diverse groups of men. Further, we
cannot rule out the possibility that the incidence findings
might be partially explained by prostate-specific antigen
(PSA) testing. However, we speculate that PSA testing is
inversely associated with heavy drinking and positively
associated with prostate cancer, such that a lack of
adjustment for PSA testing would be expected to bias risk
estimates toward the null. In addition, routine PSA testing
among asymptomatic men was not common in Finland
during the study period [29], and prostate cancer cases in
Finland tend to be more aggressive at diagnosis than in the
USA [30, 31]. Cases are thus expected to be clinically
relevant. Lastly, both underreporting of alcohol consump-
tion and changes over time are expected to be non-differ-
ential with respect to prostate cancer outcome since these
data were collected prior to diagnosis. This type of
potential exposure misclassification would therefore, if
anything, bias risk estimates toward the null. Our results on
the risk of alcohol-related death by alcohol consumption
category support the stability of alcohol consumption cat-
egory over time.
Conclusion
In this prospective, population-based cohort study of Fin-
nish male twins with a median 30 years of follow-up, we
found that heavy regular alcohol consumption and binge
drinking patterns were associated with an increased risk of
prostate cancer incidence, while abstinence was associated
with an increased risk of prostate cancer-specific mortality
compared to light alcohol consumption. Co-twin analyses
suggest that alcohol consumption may directly impact
prostate cancer risk, although they do not exclude the
possibility that the association may at least partially depend
on familial factors (genetics and shared early environment).
Future studies are needed to further explore the biologic
effects of alcohol on the prostate to elucidate how different
levels of exposure impact different stages of prostate
carcinogenesis.
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